The BELA trial: 18-month update on safety and clinical activity in patients with chronic phase CML treated with bosutirub (SKI-606) or imatinib by carlo gambacorti given during the ESH-iCMLf 13th International Conference CHRONIC MYELOID LEUKEMIA - Biology and Therapy powered by - MULTIWEBCAST

ESH-iCMLf 13th International Conference CHRONIC MYELOID LEUKEMIA - Biology and Therapy

LIST OF PRESENTATIONS/COURSES

OTHER WEBCASTS

Webcasted Presentation

BROWSE:

ALL PRESENTATIONS/COURSES

SPEAKERS

PPT SLIDES

VIDEO PODCASTS

The BELA trial: 18-month update on safety and clinical activity in patients with chronic phase CML treated with bosutirub (SKI-606) or imatinib

carlo gambacorti

[Biography]

monza, Canada

PRESENTATION

19 slide(s) – 00:10:39 – English – 2011-09-22

Extra Features Available

VIDEO PODCAST

SLIDE LIBRARY

Rate & Comment

A A A


Rate:
Please let us know how useful this content was for you and feel free to write your comments below.

Disclaimer ^{AMENDED ON January 29, 2009} | Technical Support

USER ACKNOWLEDGES AND AGREES THAT ALL DECISIONS MADE WITH THE ASSISTANCE OR USE OF THE SOFTWARE AND/OR THE WEBSITE AND/OR BASED ON CONTENT FOUND HEREIN WILL BE EXCLUSIVELY THE RESPONSIBILITY OF THE USER.

Search’n Build™